Holen Sie sich die Stockscreener-App
230.84
0.37%
0.86
Handel nachbörslich:
230.84
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ABBV?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$229.98
Offen:
$230.15
24-Stunden-Volumen:
3.36M
Relative Volume:
0.58
Marktkapitalisierung:
$407.98B
Einnahmen:
$59.64B
Nettoeinkommen (Verlust:
$2.36B
KGV:
174.18
EPS:
1.3253
Netto-Cashflow:
$19.68B
1W Leistung:
+1.29%
1M Leistung:
+1.38%
6M Leistung:
+26.62%
1J Leistung:
+29.68%
1-Tages-Spanne:
$229.74
$232.01
1-Wochen-Bereich:
$227.91
$232.01
52-Wochen-Spanne:
$164.39
$244.81
Abbvie Inc Stock (ABBV) Company Profile
Firmenname
Abbvie Inc
Sektor
Telefon
(847) 932-7900
Adresse
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
Vergleichen Sie ABBV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
230.84 | 406.46B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
LLY
Lilly Eli Co
|
1,078.73 | 964.61B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
207.56 | 500.24B | 92.15B | 25.12B | 20.46B | 10.36 |
|
NVS
Novartis Ag Adr
|
139.20 | 267.06B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
106.62 | 265.03B | 63.90B | 19.05B | 13.05B | 7.5596 |
Abbvie Inc Stock (ABBV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-11-04 | Herabstufung | DZ Bank | Buy → Hold |
| 2025-10-14 | Herabstufung | Erste Group | Buy → Hold |
| 2025-10-01 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-09-17 | Hochstufung | Berenberg | Hold → Buy |
| 2025-08-12 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-08-07 | Hochstufung | Daiwa Securities | Neutral → Outperform |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-10 | Fortgesetzt | BofA Securities | Neutral |
| 2024-12-05 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-11-04 | Hochstufung | Argus | Hold → Buy |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-06-05 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-05-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-01-29 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | Herabstufung | HSBC Securities | Buy → Hold |
| 2023-12-11 | Hochstufung | Goldman | Neutral → Buy |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-10-30 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-10-20 | Fortgesetzt | UBS | Neutral |
| 2023-09-29 | Eingeleitet | Raymond James | Outperform |
| 2023-07-25 | Eingeleitet | William Blair | Mkt Perform |
| 2023-07-14 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-05 | Herabstufung | Argus | Buy → Hold |
| 2023-03-01 | Eingeleitet | Guggenheim | Buy |
| 2023-02-22 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | Hochstufung | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-11-08 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-08-01 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | Eingeleitet | SVB Leerink | Underperform |
| 2022-05-06 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-02-28 | Herabstufung | UBS | Buy → Neutral |
| 2022-02-03 | Bestätigt | BMO Capital Markets | Outperform |
| 2022-02-03 | Bestätigt | Barclays | Equal Weight |
| 2022-02-03 | Bestätigt | BofA Securities | Neutral |
| 2022-02-03 | Bestätigt | Goldman | Neutral |
| 2022-01-13 | Eingeleitet | Redburn | Buy |
| 2022-01-12 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-11-23 | Hochstufung | Societe Generale | Hold → Buy |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-06-23 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Hochstufung | Argus | Hold → Buy |
| 2020-05-18 | Fortgesetzt | BofA/Merrill | Neutral |
| 2020-05-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-05-11 | Fortgesetzt | Morgan Stanley | Overweight |
| 2020-04-20 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | Herabstufung | Societe Generale | Buy → Hold |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-02-06 | Eingeleitet | Mizuho | Buy |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | Bestätigt | Cowen | Outperform |
| 2019-09-26 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-08-20 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-04-29 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
Alle ansehen
Abbvie Inc Aktie (ABBV) Neueste Nachrichten
Long-Term Stock Portfolio: 10 Best Stocks for the Next Decade - Insider Monkey
AbbVie Stock: Dividend Giant Balances Humira Cliff, Immunology Momentum and Wall Street Optimism - AD HOC NEWS
Sowell Financial Services LLC Sells 8,716 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Sapient Capital LLC - MarketBeat
Meyer Handelman Co. Has $39.35 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Carnegie Investment Counsel Purchases 25,146 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. (NYSE:ABBV) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
AbbVie Stock (ABBV) Outlook: Drug‑Pricing Deal Headlines, Fresh Analyst Targets, and the 2026 Catalysts Investors Are Watching - ts2.tech
AbbVie Stock (ABBV) Holds Near $230 as Year-End “Santa Rally” Takes Shape; Dividend Boost, Legal Headlines and 2026 Outlook in Focus - ts2.tech
Is AbbVie a Buy, Sell, or Hold in 2026? - Finviz
Is AbbVie a Buy, Sell, or Hold in 2026? - The Motley Fool
AbbVie Inc. $ABBV Shares Sold by Highland Capital Management LLC - MarketBeat
Aug Momentum: How AbbVie Inc stock reacts to job market dataJuly 2025 Weekly Recap & Reliable Price Action Trade Plans - moha.gov.vn
5,829 Shares in AbbVie Inc. $ABBV Bought by Regent Peak Wealth Advisors LLC - MarketBeat
AbbVie (ABBV) Stock in December 2025: Atogepant Breakthrough, Q3 Beat and 2026 Outlook After Medicare Price Cuts - ts2.tech
World Investment Advisors Increases Position in AbbVie Inc. $ABBV - MarketBeat
United States Semaglutide Market Forecast and Company Analysis Report 2025-2033 Featuring Novo Nordisk, Eli Lilly and Co, AstraZeneca, Biocon, Johnson and Johnson, Pfizer, AbbVie, and SanofiResearchAndMarkets.com - The AI Journal
AbbVie Inc. $ABBV Shares Sold by Pacer Advisors Inc. - MarketBeat
Cwm LLC Has $87.91 Million Position in AbbVie Inc. $ABBV - MarketBeat
Clayton Financial Group LLC Takes $1.43 Million Position in AbbVie Inc. $ABBV - MarketBeat
The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio - Nasdaq
AbbVie Stock (ABBV) Before the Market Opens Dec. 26, 2025: Today’s News, Earnings Outlook, Dividend Update, and Analyst Forecasts - ts2.tech
AbbVie (ABBV) Stock on Dec. 25, 2025: After-Hours Check, Today’s Headlines, and What to Watch Before the Dec. 26 Open - ts2.tech
Swedbank AB Buys 40,781 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Brookstone Capital Management - MarketBeat
AbbVie Inc. $ABBV Shares Bought by Global X Japan Co. Ltd. - MarketBeat
AbbVie Stock (ABBV) After Hours on Dec. 24, 2025: What Happened Today and What to Know Before the Next Market Open - ts2.tech
Top Stock Reports for AbbVie, Coca-Cola & Chevron - Yahoo Finance
Check out AbbVie's stock price (ABBV-CA) in real time - CNBC
AbbVie Inc. $ABBV Shares Sold by Yousif Capital Management LLC - MarketBeat
Trust Co. of Vermont Buys 12,456 Shares of AbbVie Inc. $ABBV - MarketBeat
Farther Finance Advisors LLC Has $11.04 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Exchange Traded Concepts LLC - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by Anderson Hoagland & Co. - MarketBeat
AbbVie (ABBV) Stock After Hours Today (Dec. 23, 2025): Key News, Forecasts, and What to Watch Before the Market Opens Dec. 24 - ts2.tech
AbbVie (ABBV) Stock News Today, Dec. 23, 2025: Beyond Botox Pipeline Push, Analyst Targets, and What to Watch Next - ts2.tech
AbbVie, Neurocrine End One Orilissa Patent Case Against Hetero - Bloomberg Law News
ABBV vs. AZN: Which Pharma Stock is the Better Investment Now? - Yahoo Finance
Beyond Botox: AbbVie’s push for broader gains in neurotoxin R&D - Pharma Voice
Top 5 US Healthcare Stocks By Market Value - Stocktwits
OFI Invest Asset Management Purchases 102,463 Shares of AbbVie Inc. $ABBV - MarketBeat
HBK Sorce Advisory LLC Grows Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by Goelzer Investment Management Inc. - MarketBeat
Berger Financial Group Inc Has $4.64 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie Stock After Hours (ABBV): Shares Dip After the Bell on Dec. 22, 2025 — Key News, Forecasts, and What to Watch Before Tuesday’s Open - ts2.tech
What AbbVie (ABBV)'s Restructured OSE Immunology Partnership Means For Shareholders - Yahoo Finance
AbbVie Stock News Today (Dec. 22, 2025): ABBV Holds Near $227 as Drug-Pricing Talks, Dividend Growth, and 2026 Catalysts Come Into Focus - ts2.tech
Wedge Capital Management L L P NC Sells 35,033 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV is CHICAGO TRUST Co NA's 8th Largest Position - MarketBeat
Charles Schwab Trust Co Acquires 15,502 Shares of AbbVie Inc. $ABBV - MarketBeat
11,477 Shares in AbbVie Inc. $ABBV Purchased by Corsicana & Co. - MarketBeat
Finanzdaten der Abbvie Inc-Aktie (ABBV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.03%
0.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):